# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-061817
Filing Date
2025-05-01
Accepted
2025-05-01 16:05:29
Documents
87
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | alks-20250331.htm iXBRL | 10-Q | 2526383
2 | EX-31.1 | alks-ex31_1.htm | EX-31.1 | 19368
3 | EX-31.2 | alks-ex31_2.htm | EX-31.2 | 19383
4 | EX-32.1 | alks-ex32_1.htm | EX-32.1 | 24386
5 | GRAPHIC | img78440924_0.jpg | GRAPHIC | 13021
6 | GRAPHIC | img78440924_1.jpg | GRAPHIC | 134869
7 | GRAPHIC | img78440924_2.jpg | GRAPHIC | 140207
8 | GRAPHIC | img78440924_3.jpg | GRAPHIC | 66302
| Complete submission text file | 0000950170-25-061817.txt |  | 12064467

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alks-20250331.xsd | EX-101.SCH | 1501104
90 | EXTRACTED XBRL INSTANCE DOCUMENT | alks-20250331_htm.xml | XML | 2296525

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 25902988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)